These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30965667)
1. Suicide Gene Therapy By Amphiphilic Copolymer Nanocarrier for Spinal Cord Tumor. Gwak SJ; Lee JS Nanomaterials (Basel); 2019 Apr; 9(4):. PubMed ID: 30965667 [TBL] [Abstract][Full Text] [Related]
2. Suicide gene therapy using reducible poly (oligo-D-arginine) for the treatment of spinal cord tumors. Won YW; Kim KM; An SS; Lee M; Ha Y; Kim YH Biomaterials; 2011 Dec; 32(36):9766-75. PubMed ID: 21924768 [TBL] [Abstract][Full Text] [Related]
3. Cationic, amphiphilic copolymer micelles as nucleic acid carriers for enhanced transfection in rat spinal cord. Gwak SJ; Nice J; Zhang J; Green B; Macks C; Bae S; Webb K; Lee JS Acta Biomater; 2016 Apr; 35():98-108. PubMed ID: 26873365 [TBL] [Abstract][Full Text] [Related]
4. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Chang JW; Lee H; Kim E; Lee Y; Chung SS; Kim JH Neurosurgery; 2000 Oct; 47(4):931-8; discussion 938-9. PubMed ID: 11014433 [TBL] [Abstract][Full Text] [Related]
5. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR; Kittaka M; Gordon EM; Gray B; Stins MF; McComb JG; Jovanovic S; Tabrizi P; Weiss MH; Bartus R; Anderson WF; Zlokovic BV Hum Gene Ther; 1998 May; 9(7):989-95. PubMed ID: 9607410 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy with HSV1-sr39TK/GCV exhibits a stronger therapeutic efficacy than HSV1-TK/GCV in rat C6 glioma cells. Li LQ; Shen F; Xu XY; Zhang H; Yang XF; Liu WG ScientificWorldJournal; 2013; 2013():951343. PubMed ID: 23533367 [TBL] [Abstract][Full Text] [Related]
7. Physicochemical stability and transfection efficiency of cationic amphiphilic copolymer/pDNA polyplexes for spinal cord injury repair. Gwak SJ; Macks C; Bae S; Cecil N; Lee JS Sci Rep; 2017 Sep; 7(1):11247. PubMed ID: 28900263 [TBL] [Abstract][Full Text] [Related]
8. Exogenous wt-p53 enhances the antitumor effect of HSV-TK/GCV on C6 glioma cells. Huang Q; Pu P; Xia Z; You Y J Neurooncol; 2007 May; 82(3):239-48. PubMed ID: 17102907 [TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions. Sandmair AM; Turunen M; Tyynelä K; Loimas S; Vainio P; Vanninen R; Vapalahti M; Bjerkvig R; Jänne J; Ylä-Herttuala S Cancer Gene Ther; 2000 Mar; 7(3):413-21. PubMed ID: 10766347 [TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of combined endostatin and thymidine kinase gene therapy in C6 glioma models. Chen Y; Huang H; Yao C; Su F; Guan W; Yan S; Ni Z Cancer Med; 2016 Sep; 5(9):2477-86. PubMed ID: 27366865 [TBL] [Abstract][Full Text] [Related]
11. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer. Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951 [TBL] [Abstract][Full Text] [Related]
12. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines]. Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated herpes simplex virus thymidine kinase gene therapy in BT4C rat glioma model. Tyynelä K; Sandmair AM; Turunen M; Vanninen R; Vainio P; Kauppinen R; Johansson R; Vapalahti M; Ylä-Herttuala S Cancer Gene Ther; 2002 Nov; 9(11):917-24. PubMed ID: 12386830 [TBL] [Abstract][Full Text] [Related]
14. Retrovirus-mediated herpes simplex virus thymidine kinase gene transduction renders human thyroid carcinoma cell lines sensitive to ganciclovir and radiation in vitro and in vivo. Nishihara E; Nagayama Y; Mawatari F; Tanaka K; Namba H; Niwa M; Yamashita S Endocrinology; 1997 Nov; 138(11):4577-83. PubMed ID: 9348181 [TBL] [Abstract][Full Text] [Related]
15. Limited efficacy of the HSV-TK/GCV system for gene therapy of malignant gliomas and perspectives for the combined transduction of the interleukin-4 gene. Benedetti S; Dimeco F; Pollo B; Cirenei N; Colombo BM; Bruzzone MG; Cattaneo E; Vescovi A; Didonato S; Colombo MP; Finocchiaro G Hum Gene Ther; 1997 Jul; 8(11):1345-53. PubMed ID: 9295129 [TBL] [Abstract][Full Text] [Related]
16. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model. Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258 [TBL] [Abstract][Full Text] [Related]
17. STAT3/NF-κB-Regulated Lentiviral TK/GCV Suicide Gene Therapy for Cisplatin-Resistant Triple-Negative Breast Cancer. Kuo WY; Hwu L; Wu CY; Lee JS; Chang CW; Liu RS Theranostics; 2017; 7(3):647-663. PubMed ID: 28255357 [TBL] [Abstract][Full Text] [Related]
19. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer. Tang Q; Zhang D; Wan M; Jin L Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766 [TBL] [Abstract][Full Text] [Related]
20. A designed equine herpes thymidine kinase (EHV4 TK) variant improves ganciclovir-induced cell-killing. McSorley T; Ort S; Monnerjahn C; Konrad M Biochem Pharmacol; 2014 Feb; 87(3):435-44. PubMed ID: 24316433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]